Navigation Links
Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
Date:3/4/2013

hibitor that has shown the potential to eliminate interferon from HCV treatment when combined in a regimen with faldaprevir and RBV. Phase 2 trials of this interferon-free regimen have been completed and Phase 3 HCVerso™ trials investigating this regimen are now underway.

Faldaprevir and BI 207127 are investigational compounds and not approved by the FDA. Their safety and efficacy have not been established.

Hepatitis C is a blood-born infectious disease and a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally. In the United States, an estimated 4.1 million Americans have been infected with HCV, of which approximately 3.2 million have chronic HCV infection. Since 1999 there has been a significant increase in deaths due to chronic HCV, accounting for 15,000 deaths in the United States in 2007.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and HOUSTON , May 28, 2015 /PRNewswire/ ... today reported financial results for the second quarter and three ... otherwise, are expressed in Canadian dollars and in accordance with ... ESSA recorded a net loss of $5.9 ... March 31, 2015 (Q2-2015), compared to a net loss of ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.       (Logo: ... gene silencing involves the use of double ... this material is processed into short 21-23 ...
(Date:5/28/2015)... MELVILLE, N.Y. , May 28, 2015 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, today reminded its customers that ... for dentists, physicians and veterinarians who experience operational, ... the disastrous storms in the South Central region ...
Breaking Medicine Technology:Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3
... 5 Abbott (NYSE: ABT ) will present at the ... in New York City .  Miles D. White, chairman and chief ... a.m. Central time . , , ... audio webcast of the presentation will be accessible through Abbott,s Investor Relations Web ...
... is available in its catalogue: , , , ... http://www.reportlinker.com/p0187226/The-World-Anesthesia-Drug-Market.html , ... Drug Market - focuses on three primary segments of anesthesia: , , , ... , , , ...
Cached Medicine Technology:Reportlinker Adds The World Anesthesia Drug Market 2Reportlinker Adds The World Anesthesia Drug Market 3Reportlinker Adds The World Anesthesia Drug Market 4Reportlinker Adds The World Anesthesia Drug Market 5Reportlinker Adds The World Anesthesia Drug Market 6Reportlinker Adds The World Anesthesia Drug Market 7Reportlinker Adds The World Anesthesia Drug Market 8Reportlinker Adds The World Anesthesia Drug Market 9Reportlinker Adds The World Anesthesia Drug Market 10
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will return ... and highly demanded Basic and Advanced Classic Seminars ... 5:30 pm each day. Certification is available upon completion of the ... on June 14 from 12:00 pm to 6:00 pm. Both the ... Hotel & Casino in downtown Las Vegas. , Seminar ...
(Date:5/29/2015)... Dr. Rodger Murphree, author of ... is now offering free weekly call in teleconferences ... ways to reduce symptoms associated with fibromyalgia including ... brain fog. , To find out more ... call in teleconferences simply go to http://www.endfibronow.com ...
(Date:5/29/2015)... Designed with the versatile athlete in mind, ... all new, exclusive line of supplementation called The 24/7 ... and greatest, high impact, result driven ingredients that have ... 24/7 Series can be used by anyone from bodybuilders ... fitness enthusiasts. There are no stimulant based ingredients that ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 ... their expertise to the Los Angeles County clinics ... diagnostic procedures are now being offered at all ... Orange County, and San Bernardino County. , ... motor neurons send electrical impulses throughout the ...
(Date:5/29/2015)... As spring has sprung and summer approaches, ... increased in popularity as people finish plans for pool ... While a perennial favorite, the early Memorial Day ... weeks earlier than usual. , Similar to previous years, ... to prefer the Patio series rooms which are available ...
Breaking Medicine News(10 mins):Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... researcher Olga Raz is all set to launch her diet plan, which ... of the world through her book The Bread for Life Diet: The ... of it – up to 12 slices a day for women and ... carbohydrates -- and is a two-part program. ,The bread is ...
... diseases all around the world. Researchers have now come ... an alternative to injections// for controlling their blood sugar. ... FDA. ,If approved, the drug, known as Exubera, ... by millions worldwide. The product works by releasing an ...
... show that increasing intake of the common flavouring at mealtimes ... less and reduce cravings brought on by sugar peaks// after ... consumed by 12 healthy subjects and their glucose and insulin ... volunteers were given three amounts of vinegar (18, 23 and ...
... weight for health, it is equally important to lose weight ... of fruits, vegetables, whole grains and other such nutritious foods// ... and follow and is more effective than the conventional diet ... ,A low-fat, plant-based diet has been found to be ...
... cholangiocarcinoma is a type of bile duct cancer. Conventional therapy ... tumor, which may require removing part of the liver. Survival ... to 35 percent, and many patients cannot be treated this ... liver. ,Cholangiocarcinoma is a relatively uncommon malignant tumor that ...
... the world is like a stage “, written by William ... to read, nice to listen but a little difficult to ... been given to aging, very little is done to understand ... us would have been embarrassed by the odd behavior of ...
Cached Medicine News:Health News:Exubera could mean the end of an insulin injection era for diabetics 2Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Combined modality approach for effective treatment and enhanced survival in bile duct cancer 2Health News:Do not regret growing older, It is a privilege denied to many 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: